Received Apr 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | — | — |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 2 | — | — |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 3 | — | — |
Caller had a question about RECOMBIVAX HB. Pharmacist stated that he has an employee that had received 3 doses of RECOMBIVAX HB in the past and the titer showed below threshold. Consent was obtained to follow up with the HCP. No additional AE/PQC.; This spontaneous report was received from a pharmacist and refers to a 24-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the first, second and third dose of with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), solution for injection (lot # and expiration date were not reported) for Prophylaxis. On an unknown date, the Pharmacist stated that he had an employee that had received 3 doses of the vaccine, and the titer showed below threshold. At the reporting time, the outcome of the event was not reported. The causal relationship between the event and Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) was unknown.